abnormalities in specific brain regions; however, the extent to which brain network topology is altered by OAB remains unknown. The aim of this study is to use functional magnetic resonance imaging (fMRI) to explore brain small-world network changes during bladder filling in women with OAB as well as in healthy controls. To our knowledge, this is the first study to apply the concepts of small-world brain network topology to micturition.
INTRODUCTION AND OBJECTIVES: Androgen deprivation therapy (ADT) is commonly used for the management of localized and metastatic prostate cancer. There is mounting evidence that ADT may expedite loss of brain volume, which may hasten cognitive decline. In this study we aim to quantify the loss of cortical brain volume in patients on ADT.
METHODS: We retrospectively analyzed baseline and follow up CT head scans of 14 men prior to and after initiation of ADT. Men underwent CT head imaging for non-trauma/ischemic indications. All CT imaging were reviewed using 3D planimetry software (3D Splicer Ò, Version 4.0). Brain, ventricular surface area and volumes were assessed via segmentation protocol. All volumes and surface areas were calculated using dedicated, automated software ( Figure) . Baseline socio-demographic variables, comorbidities, and risk factors were collected retrospectively. Paired t-test was utilized to assess change in brain volume prior to and after initiation of ADT RESULTS: A total of 14 patients were analyzed in the study. Mean age 74.36 yo (AE13.76), with median ADT duration of 9.5 months (IQR 6.0, 16.25) , with a median washout period of 11 months ( IQR 6.5, 20.25) prior to follow up CT scan. Overall, 5 (35.7%) and 9 (64.3%) were started on either Leuprolide acetate plus Bicalutamide, vs Leuprolide acetate alone, respectively. Additionally, 6 (42.9%) had oligo-metastatic disease to the bone at the time of ADT initiation.
Compared to baseline CT imaging, patients on ADT experienced statistically significant brain volume loss , p[0.027)). Similarly, men on androgen deprivation experienced increase in ventricular volume (22.166 cm3 (95% CI -0.703, 45.035) p[0.056)). There was no difference in the surface area of the cortex or ventricles among the pre and post ADT head imaging CONCLUSIONS: Our study found that men with prostate cancer experience significant cortical brain volume loss as well as ventricular volume expansion after initiation of androgen deprivation therapy.
Source of Funding: none

PD23-03 HIGH RESOLUTION 29 MHZ MICRO-ULTRASOUND IN THE DIAGNOSIS OF PRIMARY AND RECURRENT PROSTATE CANCER
Laurence Klotz*, Dixon Woon, Toronto, Canada INTRODUCTION AND OBJECTIVES: High resolution microultrasound (micro-US) is a novel technology which offers the potential to image PCa and perform targeted biopsies with significantly improved cancer visualization compared to conventional ultrasound, potentially obviating the need for MRI. Micro-US incorporates a scoring system (PRIMUS, Grades 1-5) that is similar to the PIRADS-2 system used for MRI. This facilitates assignment of a risk category based on the characteristics of the region of interest. We evaluate the NPV and PPV for each PRIMUS risk category.
METHODS: 50 patients underwent prostate biopsy using micro-US (ExactVu micro-US, Exact Imaging, Markham, Canada). 32 were undiagnosed men at risk for PCa, and 18 had been previously treated with focal therapy with HIFU or TULSA and were undergoing post treatment biopsies. In the undiagnosed patients, targeted and 12 core systematic biopsies were performed. 28 had had a prior MRI. Physicians were blinded to the MRI results at the time of biopsy.
